Enhanced genetic modification of adult growth factor mobilized peripheral blood hematopoietic stem and progenitor cells with rapamycin. - Wikidata - wikimedia - TriplyDB

Enhanced genetic modification of adult growth factor mobilized peripheral blood hematopoietic stem and progenitor cells with rapamycin.

Enhanced genetic modification of adult growth factor mobilized peripheral blood hematopoietic stem and progenitor cells with rapamycin.

http://www.wikidata.org/entity/Q34273081

about

Stem cell gene therapy for HIV: strategies to inhibit viral entry and replication.Prostaglandin E2 Increases Lentiviral Vector Transduction Efficiency of Adult Human Hematopoietic Stem and Progenitor Cells.

P2860

Q38314119-A153F2D4-39CE-4772-B930-A0B394DD9CC6 Q45873947-FF5AA678-491E-490C-8FED-E9317E01D93F

P2860

Enhanced genetic modification of adult growth factor mobilized peripheral blood hematopoietic stem and progenitor cells with rapamycin.

http://www.wikidata.org/entity/Q34273081

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Enhanced genetic modification ...... ogenitor cells with rapamycin.

@ast

Enhanced genetic modification ...... ogenitor cells with rapamycin.

@en

Enhanced genetic modification ...... ogenitor cells with rapamycin.

@nl

type

label

Enhanced genetic modification ...... ogenitor cells with rapamycin.

@ast

Enhanced genetic modification ...... ogenitor cells with rapamycin.

@en

Enhanced genetic modification ...... ogenitor cells with rapamycin.

@nl

prefLabel

Enhanced genetic modification ...... ogenitor cells with rapamycin.

@ast

Enhanced genetic modification ...... ogenitor cells with rapamycin.

@en

Enhanced genetic modification ...... ogenitor cells with rapamycin.

@nl

P1433

Q34273081-15B16F58-9510-483E-A6F1-6F819DB8F0F6

P1476

Q34273081-B01524AB-B461-434C-B192-2F6D6D60C33C

P2093

Q34273081-0C755F1A-3C2C-4794-90B3-B45D7046EE8B

Q34273081-0CCBEA44-C7AD-4AC8-B807-5D3CBEB5760F

Q34273081-2551C45C-4814-4A2C-A883-E4506D5072C2

Q34273081-33DCA99F-8857-4EA2-86C9-57554AABB7A3

Q34273081-4AEA82E0-BEDF-4F68-B537-F1C7DD8F8E85

Q34273081-839A064B-A68C-442F-B273-1E425EA71C51

Q34273081-876ABACB-69E4-4FE7-A1C6-1D50F80B25A3

Q34273081-903F5AF5-0086-42F9-BFEC-97581E13E415

Q34273081-B44F3341-39AD-423F-8497-D0F7EB53C73A

Q34273081-C0CB04EC-128D-433D-855C-9C83C785C371

P2860

Q34273081-00AD1BD9-580A-4FB2-A402-CDB830B8CD46

Q34273081-02F3CB89-B539-4BD5-8E9E-D554314CBD38

Q34273081-03CD680E-0F37-4753-AD2A-8C8172812B0C

Q34273081-1B458B20-9E4B-4442-BFC9-0CBF81AB0AB9

Q34273081-2009D26E-E18D-4B4C-8F6B-C35BBEA3E98E

Q34273081-2827A536-06C4-486C-8316-0E0C6D777710

Q34273081-49C69C7C-1856-4880-8A31-38F5C15133CC

Q34273081-4BD8FE02-814E-41DC-9A3D-5E0C07FA8066

Q34273081-4DF9F2F3-BE4E-4666-BF8E-9A510BA7C3A5

Q34273081-562F2DA8-E7DA-48C5-A8B1-F124953982CD

P304

Q34273081-32654C8D-9874-4406-ADF3-576325C4A393

P31

Q34273081-B137054C-884B-4D4A-B5D5-9F8EECDEC871

P356

Q34273081-BB8A0531-4E17-4247-A9D3-B03D6BE893E6

P433

Q34273081-D51D99AE-E074-49E3-943C-7FE2DAD97934

P478

Q34273081-01CDCEBD-ABB3-428B-B317-BCC11E1752D0

P577

Q34273081-26F30034-4869-44E5-A092-C1EA3659CABF

P698

Q34273081-D173AC6C-A5F2-4310-9BCF-B1779FC2F4B5

P932

Q34273081-FFEEE6C3-23B4-4FD0-9A2C-25258DCAFD3C

P356

P1433

Stem Cells Translational Medicine

P1476

Enhanced genetic modification ...... ogenitor cells with rapamycin.

@en

P2093

Agnes M Gardner

http://www.w3.org/2001/XMLSchema#string

Angel Gu

http://www.w3.org/2001/XMLSchema#string

Anitha Rao

http://www.w3.org/2001/XMLSchema#string

Chy-Anh Tran

http://www.w3.org/2001/XMLSchema#string

David L DiGiusto

http://www.w3.org/2001/XMLSchema#string

Elizabeth W Epps

http://www.w3.org/2001/XMLSchema#string

Jin-Hui Wang

http://www.w3.org/2001/XMLSchema#string

Lijing Li

http://www.w3.org/2001/XMLSchema#string

Mónica Torres-Coronado

http://www.w3.org/2001/XMLSchema#string

Nancy Gonzalez

http://www.w3.org/2001/XMLSchema#string

P2860

mTOR inhibitors in advanced renal cell carcinoma

Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia

Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells

A comparison of Ku0063794, a dual mTORC1 and mTORC2 inhibitor, and temsirolimus in preclinical renal cell carcinoma models

Development of Hematopoietic Stem Cell Based Gene Therapy for HIV-1 Infection: Considerations for Proof of Concept Studies and Translation to Standard Medical Practice

mTOR regulation of autophagy

Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials.

Towards a clinically relevant lentiviral transduction protocol for primary human CD34 hematopoietic stem/progenitor cells.

Optimized lentiviral vectors for HIV gene therapy: multiplexed expression of small RNAs and inclusion of MGMT(P140K) drug resistance gene

Efficient and stable MGMT-mediated selection of long-term repopulating stem cells in nonhuman primates.

P304

1199-1208

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5966/SCTM.2014-0010

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2014-08-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25107584

http://www.w3.org/2001/XMLSchema#string

P932

4181393

http://www.w3.org/2001/XMLSchema#string